Antibody patents: Danger ahead for biologics
The evolution of antibody written description standards at the USPTO has put some drug portfolios at risk, say John Heithaus and Gerald Murphy of Birch, Stewart, Kolasch & Birch.
Latest news
GSK unites with CRISPR pioneer Doudna
14-06-2019
British-based pharmaceutical company GSK has entered into a five-year collaboration with the University of California to explore how gene mutations cause disease and accelerate drug discovery.
50 Key Influencers In The Life Sciences
- LSIPR 50 2018: Robert Nelsen 05-09-2018
- LSIPR 50 2018: Stephen Knight 04-09-2018
Regions
- Marketing authorisation: Splitting the bill 20-05-2019
- SPCs: extending protection lifespan 20-05-2019
Sectors
- Precision medicine: The personal touch 21-05-2019
- Shire Pharmaceuticals: A culture of excellence 21-05-2019
